44
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The human 18S rRNA m 6A methyltransferase METTL5 is stabilized by TRMT112

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          N6-methyladenosine (m 6A) has recently been found abundantly on messenger RNA and shown to regulate most steps of mRNA metabolism. Several important m 6A methyltransferases have been described functionally and structurally, but the enzymes responsible for installing one m 6A residue on each subunit of human ribosomes at functionally important sites have eluded identification for over 30 years. Here, we identify METTL5 as the enzyme responsible for 18S rRNA m 6A modification and confirm ZCCHC4 as the 28S rRNA modification enzyme. We show that METTL5 must form a heterodimeric complex with TRMT112, a known methyltransferase activator, to gain metabolic stability in cells. We provide the first atomic resolution structure of METTL5–TRMT112, supporting that its RNA-binding mode differs distinctly from that of other m 6A RNA methyltransferases. On the basis of similarities with a DNA methyltransferase, we propose that METTL5–TRMT112 acts by extruding the adenosine to be modified from a double-stranded nucleic acid.

          Related collections

          Most cited references43

          • Record: found
          • Abstract: not found
          • Article: not found

          Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants

          W Kabsch (1993)
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Tuning the ribosome: The influence of rRNA modification on eukaryotic ribosome biogenesis and function

            ABSTRACT rRNAs are extensively modified during their transcription and subsequent maturation in the nucleolus, nucleus and cytoplasm. RNA modifications, which are installed either by snoRNA-guided or by stand-alone enzymes, generally stabilize the structure of the ribosome. However, they also cluster at functionally important sites of the ribosome, such as the peptidyltransferase center and the decoding site, where they facilitate efficient and accurate protein synthesis. The recent identification of sites of substoichiometric 2′-O-methylation and pseudouridylation has overturned the notion that all rRNA modifications are constitutively present on ribosomes, highlighting nucleotide modifications as an important source of ribosomal heterogeneity. While the mechanisms regulating partial modification and the functions of specialized ribosomes are largely unknown, changes in the rRNA modification pattern have been observed in response to environmental changes, during development, and in disease. This suggests that rRNA modifications may contribute to the translational control of gene expression.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Ribosome biogenesis in cancer: new players and therapeutic avenues

              The ribosome is a complex molecular machine composed of numerous distinct proteins and nucleic acids and is responsible for protein synthesis in every living cell. Ribosome biogenesis is one of the most multifaceted and energy- demanding processes in biology, involving a large number of assembly and maturation factors, the functions of which are orchestrated by multiple cellular inputs, including mitogenic signals and nutrient availability. Although causal associations between inherited mutations affecting ribosome biogenesis and elevated cancer risk have been established over the past decade, mechanistic data have emerged suggesting a broader role for dysregulated ribosome biogenesis in the development and progression of most spontaneous cancers. In this Opinion article, we highlight the most recent findings that provide new insights into the molecular basis of ribosome biogenesis in cancer and offer our perspective on how these observations present opportunities for the design of new targeted cancer treatments.
                Bookmark

                Author and article information

                Journal
                Nucleic Acids Res
                Nucleic Acids Res
                nar
                Nucleic Acids Research
                Oxford University Press
                0305-1048
                1362-4962
                05 September 2019
                22 July 2019
                22 July 2019
                : 47
                : 15
                : 7719-7733
                Affiliations
                [1 ]BIOC, CNRS, Ecole polytechnique, Institut Polytechnique de Paris, F-91128 Palaiseau, France
                [2 ]RNA Molecular Biology, ULB Cancer Research Center (U-CRC), Fonds de la Recherche Scientifique (F.R.S./FNRS), Université Libre de Bruxelles, B-6041 Charleroi-Gosselies, Belgium
                [3 ]Department of Pharmacology, Weill Medical College, Cornell University, NY 10065, New York, USA
                [4 ]Department of Molecular Biology, University Medical Center Göttingen, 37073 Göttingen, Germany
                Author notes
                To whom correspondence should be addressed. Tel: +32 265 09771; Email: denis.lafontaine@ 123456ulb.ac.be
                Correspondence may also be addressed to Marc Graille. Tel: +33 016 9334890; Email: marc.graille@ 123456polytechnique.edu

                The authors wish it to be known that, in their opinion, the first two authors should be regarded as Joint First Authors.

                Author information
                http://orcid.org/0000-0002-2458-7868
                http://orcid.org/0000-0002-7853-5852
                http://orcid.org/0000-0001-7295-6288
                Article
                gkz619
                10.1093/nar/gkz619
                6735865
                31328227
                92aa35cf-5b6e-481e-907b-c47e1d64ecc9
                © The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@ 123456oup.com

                History
                : 12 July 2019
                : 14 June 2019
                : 09 April 2019
                Page count
                Pages: 15
                Funding
                Funded by: Agence Nationale pour la Recherche
                Award ID: ANR-14-CE09-0016
                Award ID: ANR-16-CE11-0003
                Funded by: CNRS 10.13039/501100004794
                Funded by: PICS 10.13039/100011346
                Award ID: PICS07484
                Funded by: Fonds de la Recherche Scientifique 10.13039/501100002661
                Award ID: CDR J.0095.19-33696322
                Funded by: Région Wallonne
                Award ID: First Spin-Off n°1810070-RIBOcancer
                Funded by: National Institutes of Health 10.13039/100000002
                Award ID: NS111631
                Award ID: CA186702
                Funded by: Deutsche Forschungsgemeinschaft 10.13039/501100001659
                Award ID: SPP1784: BO3442/2-2
                Categories
                NAR Breakthrough Article

                Genetics
                Genetics

                Comments

                Comment on this article